Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Japan
  4. Japan Exchange
  5. Terumo Corporation
  6. Summary
    4543   JP3546800008

TERUMO CORPORATION

(4543)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Japan Exchange
07/15/2021 07/16/2021 07/19/2021 07/20/2021 07/21/2021 Date
4297 4235 4181 4137 4174 Last
1394800 1710800 1587100 2125300 1736700 Volume
-1.33% -1.44% -1.28% -1.05% +0.89% Change
Estimated financial data (e)
Sales 2022 676 B 6 113 M 6 113 M
Net income 2022 89 911 M 813 M 813 M
Net Debt 2022 28 293 M 256 M 256 M
P/E ratio 2022 35,0x
Yield 2022 0,73%
Sales 2023 728 B 6 585 M 6 585 M
Net income 2023 104 B 936 M 936 M
Net cash position 2023 17 960 M 162 M 162 M
P/E ratio 2023 30,4x
Yield 2023 0,79%
Capitalization 3 156 B 28 549 M 28 540 M
EV / Sales 2022 4,71x
EV / Sales 2023 4,31x
Nbr of Employees 26 482
Free-Float 95,8%
More Financials
Company
TERUMO CORPORATION is a manufacturer of medical supplies. The Company operates in three segments. The Cardiac and Vascular Company segment is engaged in the manufacture of catheter system and cardiopulmonary system products, the import of the cardiopulmonary systems and artificial blood vessels, as well as the sale of products mainly to hospitals and clinics nationwide through agents. The Hospital Company segment is... 
More about the company
Ratings of Terumo Corporation
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
A-
More Ratings
All news about TERUMO CORPORATION
07/20TERUMO : and UMCU strengthen their partnership to develop solutions in Intervent..
AQ
06/30Japanese shares drop on worries about COVID-19 resurgence
RE
06/18Japanese stocks end lower; Toyota, financials weigh on Topix
RE
06/17Nikkei tracks Nasdaq's solid finish overnight, Toyota drags Topix
RE
05/13TERUMO : Donates Additional USD 1 Million to Support the COVID-19 Solidarity Res..
AQ
05/13Nikkei slumps to 4-month low as inflation scare hits expensive shares
RE
05/12Nikkei slumps to 4-month low as inflation scare hits expensive shares
RE
05/12Terumo Corporation Provides Dividend Guidance for the Year Ending March 2022
CI
05/12Terumo Corporation Announces Dividend for the Year Ended March 2021 and Provi..
CI
05/12Terumo Corporation Provides Consolidated Earnings Guidance for the Fiscal Yea..
CI
05/12Terumo Corporation Reports Consolidated Earnings Results for the Year Ended M..
CI
05/12TERUMO CORPORATION : Press Release
CO
05/12TERUMO CORPORATION : Annual results
CO
04/14TERUMO : Corporate Governance Report
PU
04/12TERUMO : is building a Global Therapeutic Interventional Oncology team to offer ..
AQ
More news
News in other languages on TERUMO CORPORATION
07/01Nikkei 225 : Borsa Tokyo in calo, nuovi contagi alimentano timori per lenta r..
05/11MÄRKTE ASIEN/Talfahrt bei Technologiewerten - Inflationssorgen belasten
03/10PLANETA BOLSA : La revista de prensa del miércoles 10 de marzo 2021
03/10PLANÈTE BOURSE  : La revue de presse du mercredi 10 mars 2021
02/15Coronavirus/Japon-Une pénurie de seringue ralentit la vaccination
More news
Chart TERUMO CORPORATION
Duration : Period :
Terumo Corporation Technical Analysis Chart | 4543 | JP3546800008 | MarketScreener
Technical analysis trends TERUMO CORPORATION
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 14
Last Close Price 4 174,00 JPY
Average target price 4 967,86 JPY
Spread / Average Target 19,0%
EPS Revisions
Managers and Directors
Shinjiro Sato President, CEO & Representative Director
Naoki Muto Chief Financial & Accounting Officer
Takayoshi Mimura Chairman
Katsuya Takeuchi Chief Information Officer & Executive Officer
Kazuhisa Senshu Chief Clinical & Regulatory Affairs Officer
Sector and Competitors
1st jan.Capi. (M$)
TERUMO CORPORATION-3.20%30 287
ABBOTT LABORATORIES10.33%200 283
MEDTRONIC PLC9.73%168 081
BECTON, DICKINSON AND COMPANY0.34%70 145
HOYA CORPORATION3.33%50 251
ALIGN TECHNOLOGY, INC.19.44%48 667